Peninsula Research Associates

Executive Summary

Peninsula Research Associates (PRA) is a private, U.S.-based clinical research organization (CRO) founded in 2015 and headquartered in San Mateo, California. PRA specializes in conducting high-quality clinical trials across therapeutic areas including vaccines (RSV, influenza, COVID-19, pneumonia), asthma, dermatology, obesity, and weight management. The company's primary value proposition is enabling patient access to investigational medications before they become widely available, thereby accelerating drug development and improving treatment outcomes. Operating at the pre-clinical stage, PRA partners with biopharmaceutical sponsors to manage study design, patient recruitment, and data collection, leveraging its expertise in complex trial protocols. While PRA does not develop its own drugs, its role as a CRO positions it as a critical enabler in the clinical development ecosystem, with potential to benefit from increasing outsourced clinical trial demand.

Upcoming Catalysts (preview)

• Q3 2026Award of new vaccine trial contracts (RSV or combination vaccines)70% success
• Q4 2026Expansion of obesity/weight management trial portfolio60% success
• Q1 2027Partnership with a large pharma for dermatology indication50% success